ContractopenUnited States
TO ADVANCE THE DEVELOPMENT OF THE SHIGETEC VACCINE THROUGH CGMP MANUFACTURING AND RELEASE OF ADDITIONAL CGMP LOTS FOR USE IN A SERIES OF PHASE 2 CLINICAL TRIALS.
National Institutes of HealthDescription
TO ADVANCE THE DEVELOPMENT OF THE SHIGETEC VACCINE THROUGH CGMP MANUFACTURING AND RELEASE OF ADDITIONAL CGMP LOTS FOR USE IN A SERIES OF PHASE 2 CLINICAL TRIALS. Recipient: EVELIQURE BIOTECHNOLOGIES GMBH Award Amount: $11.48M
Requirements
Source: USASpending.gov
Interested in this contract?
Sign up to get match scores, track opportunities, and manage proposals with AI-powered tools.
Contract Details
Value Range
Up to $11,480,000
Deadline
March 31, 2027
Geographic Scope
United States
Status
open
External Links
View Original ListingSee how well this contract matches your organization.
Get Your Match Score